by Dolly the Sheep | Jan 28, 2026 | Bispecific Antibodies, Drug Discovery, Immunology, in vivo Studies
BROCHURE BY BIO X CELL Scale Your Science with Functional RUO Bispecific Antibodies: From Ready-to-Ship Reagents to Custom Bispecific Designs for Translational Research Clarify Dual-Target Mechanisms Across Preclinical and Translational Models Bispecific antibodies...
by Dolly the Sheep | Jan 28, 2026 | Bispecific Antibodies, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL Bispecific Antibody 101: Essential Tools for Research Bispecific antibodies are reshaping how researchers study immune and tumor biology by enabling engagement of two molecular targets at once. This capability supports deeper investigation across...
by Dolly the Sheep | Jan 28, 2026 | Bispecific Antibodies, Drug Discovery, Immunology, in vivo Studies
TECHNOLOGY HIGHLIGHTS Bispecific Antibodies: Your Essential Partner for Preclincal Research Tools – From Early Discovery to Preclinical Validation Bridging the Gap in Drug Discovery – Your Partner for Quality Drug Discovery Reagents LAB-A-PORTER empowers...
by Dolly the Sheep | Jan 14, 2026 | Cancer, CRISPR, Immunology, Molecular, Neurology, Promotion, Stem Cell, Virology
PROMOTION: GENETEX X LAB-A-PORTER To support your research needs on antibodies, GeneTex and LAB-A-PORTER are thrilled to announce a special promotion. From now until 31 March 2026, upon purchase of selected* 100 μl primary antibodies from GeneTex, you can get one...
by Dolly the Sheep | Dec 18, 2025 | Company News, in vivo Studies, LAB-A-PORTER Insiders, News, Organoids, Stem Cell
COMPANY UPDATES Welcome to the third issue of LAB-A-PORTER company newsletter! We are excited to close out 2025 with an edition dedicated to the “superpowers” that drive scientific innovation. At LAB-A-PORTER, we know that the path to discovery is rarely a...